A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis-Reference-Cited by-同舟云学术

A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis

Published:2018-08-14 Issue:2 Volume:33 Page:288-297
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Dirschka T.¹²,Ekanayake-Bohlig S.³,Dominicus R.⁴,Aschoff R.⁵,Herrera-Ceballos E.⁶,Botella-Estrada R.⁷⁸,Hunfeld A.⁹,Kremser M.⁹,Schmitz B.⁹,Lübbert H.⁹,Puig S.¹⁰¹¹¹²

Affiliation:

1. CentroDerm GmbH; Wuppertal Germany

2. Faculty of Health; University Witten/Herdecke; Witten Germany

3. MensingDerma Research GmbH; Hamburg Germany

4. ProDerma; Dülmen Germany

5. Department of Dermatology; University Hospital Carl Gustav Carus; Technical University Dresden; Dresden Germany

6. Department of Dermatology; Hospital Clinico Virgen de la Victoria; Malaga Spain

7. University of Valencia; Valencia Spain

8. Department of Dermatology; Hospital Universitari i Politécnic la Fe; Valencia Spain

9. Biofrontera Bioscience GmbH; Leverkusen Germany

10. Hospital Clinic de Barcelona; Barcelona Spain

11. University of Barcelona; Barcelona Spain

12. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER); Barcelona Spain

Funder

Biofrontera Bioscience GmbH

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.15185/fullpdf

Reference27 articles.

1. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma;Morton;J Eur Acad Dermatol Venereol,2013

2. Epidemiology of solar keratoses;Frost;Br J Dermatol,1994

3. Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology;Braathen;J Eur Acad Dermatol Venereol,2012

4. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study;Wiegell;Br J Dermatol,2008

5. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study;Kellner;Br J Dermatol,2015

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and perspectives in use of semisolid formulations for photodynamic methods;European Journal of Pharmaceutics and Biopharmaceutics;2024-09

2. Efficacy of Photodynamic Therapy in the Treatment of Actinic Keratosis: A Network Meta-Analysis;Journal of Cutaneous Medicine and Surgery;2024-08-05

3. The use of photodynamic therapy in medical practice;Frontiers in Oncology;2024-05-08

4. Squamous Cell Carcinoma and its Precursors;Rook's Textbook of Dermatology;2024-03-19

5. European consensus‐based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV‐induced dysplasia and field cancerization on behalf of European Association of Dermato‐Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes);Journal of the European Academy of Dermatology and Venereology;2024-03-07